Back in April of this year we did an NFTRH+ on BioPharma ABBV and its amazingly similar setup to 2016’s NFTRH+ pick, LRCX. The original target was noted as 84, which ABBV is still on track for. But in weekly NFTRH reports that target was subsequently adjusted to a less conservative 88 and a new interim target of 75 was added several weeks ago.
Well, at a high of 75.04 it’s ding ding ding for target #1.
As posted recently I took the profit on ABBV in the low 70s and after the sector corrected I replaced it with well, the sector, in the form of XLV, which has a very similar chart to ABBV. That was based on our recent Healthcare bull flags posts.
Anyway, target #1 is in on this one… wheee!
Subscribe to NFTRH Premium for your 40-55 page weekly report, interim updates and NFTRH+ chart and trade ideas or the free eLetter for an introduction to our work. Or simply keep up to date with plenty of public content at NFTRH.com and Biiwii.com. Also, you can follow via Twitter @BiiwiiNFTRH, StockTwits, RSS or sign up to receive posts directly by email (right sidebar).